Gilon Co., Ltd. announced that it will receive 500,000 shares at an issue price of KRW 1,000 for gross proceeds of KRW 500,000,000 on November 30, 2021. The transaction include participation from Solco Biomedical Co., Ltd. The transaction is expected to close on December 7, 2021. The transaction was approved by the board of director of the company.

The securities issued through third-party allocation method.